Yuekang Pharmaceutical (688658.SH) is planning to issue H-shares and list on the Hong Kong Stock Exchange.

Financial APP news, Yuekang Pharmaceutical (688658.SH) announced that, in order to further enhance the company's overall competitiveness, enhance the company's international brand image, and better utilize the international capital market and diversify financing channels, the company plans to issue shares overseas (H shares) and list on the main board of The Stock Exchange of Hong Kong Limited (referred to as the "Hong Kong Stock Exchange").